Nevertheless, the classification of PAX5 negative cases with CHL morphology and cytotoxic features as described by Asano et al. [87] remain controversial and will require more work on the genetic and gene expression profile. This evidence concerns the gene PAX5 and classic Hodgkin lymphoma.